Clarus Therapeutics Patents – Key Insights and Stats

Clarus Therapeutics has a total of 64 patents globally, out of which 42 have been granted. Of these 64 patents, only 78% patents of the portfolio are active. Japan is where Clarus Therapeutics has filed the maximum number of patents, followed by Europe and Korea. The USA seems to be the main focused R&D center and is also the origin country of Clarus Therapeutics.

Clarus Therapeutics was founded in the year 2003 by Robert E. Dudley. Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women also company provides products for the treatment of erectile dysfunction, reduced sex drive, fatigue, mild depression, and increased body fat.

Do read about some of the most popular patents of Clarus Therapeutics which have been covered by us in this report and also you can find Clarus Therapeutics’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Clarus Therapeutics’s patent portfolio.

How many patents does the founder and CEO of Crusoe Energy have?

The founder and CEO Robert E. Dudley have 186 patents.

How many patents does Clarus Therapeutics have?

Clarus Therapeutics has a total of 64 patents globally. These patents belong to 21 unique patent families. Out of 64 patents, 50 patents are active.

How Many Patents did Clarus Therapeutics File Every Year?

Clarus Therapeutics Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantClarus Therapeutics Applications FiledClarus Therapeutics Patents Granted
201112
201261
201332
2014610
201537
20165
20176
201811
201912
20201
20211
20224

How many Clarus Therapeutics patents are Alive/Dead?

Worldwide Patents

Clarus Therapeutics Patents Portfolio

How Many Patents did Clarus Therapeutics File in Different Countries?

Clarus Therapeutics Worldwide Patents

Countries in which Clarus Therapeutics Filed Patents

CountryPatents
Japan6
Europe6
Korea (South)5
Australia5
Russia4
China4
Hong Kong (S.A.R.)3
Canada3
Germany3
Brazil2
Denmark2
India2
Mexico2
South Africa1
Italy1
Portugal1
Indonesia1
Singapore1
New Zealand1
Spain1
Philippines1
Costa Rica1
Israel1

Where are the Research Centres of Clarus Therapeutics Patents Located?

Research Centres of Clarus Therapeutics Patents

Best Clarus Therapeutics Patents

WO2011129812A1 is the most popular patent in the Clarus Therapeutics portfolio. It has received 15 citations so far from companies like Lipocine Inc, Merck Sharp & Dohme, and Murty Pharmaceuticals.

What Percentage of Clarus Therapeutics US Patent Applications were Granted?

Clarus Therapeutics (Excluding its subsidiaries) has filed 37 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 11 have been granted leading to a grant rate of 39.29%.

Below are the key stats of Clarus Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Clarus Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Global Patent Group Cti3539.29%
Katten Muchin Rosenman Llp20%

What are Clarus Therapeuticskey innovation segments?

What Technologies are Covered by Clarus Therapeutics?

The chart below distributes patents filed by Clarus Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Clarus Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Clarus Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Clarus Therapeutics?

Updated on January 2, 2023

Was this article helpful?

Leave a Comment